Other

Mylan also owns Somerset Pharmaceuticals Inc., a proprietary research and development company located in Tampa, Fla. Somerset developed EMSAM^®, a transdermal patch for the treatment of major depressive disorder, currently manifactured by Mylan Technologies and marketed in the U.S. by Dey.